aTyr Pharma, Inc.
LIFENext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for LIFE. That does not mean none is planned.
Get an email about LIFE's next catalysts
Track aTyr Pharma (LIFE) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
Efzofitimod 3 mg/kg
Pulmonary Sarcoidosis
ATYR1940
Limb-Girdle Muscular Dystrophies
efzofitimod 450 mg
Interstitial Lung Disease
Efzofitimod 1 mg/kg
SARS-CoV-2 (COVID-19) Severe Pneumonia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Efzofitimod 3 mg/kg | Phase 3 | Pulmonary Sarcoidosis | - | - |
ATYR1940 | Phase 2 | Limb-Girdle Muscular Dystrophies | - | - |
efzofitimod 450 mg | Phase 2 | Interstitial Lung Disease | - | - |
Efzofitimod 1 mg/kg | Phase 2 | SARS-CoV-2 (COVID-19) Severe Pneumonia | - | - |
Pulmonary Sarcoidosis
1 drug in this indication
Limb-Girdle Muscular Dystrophies
1 drug in this indication
SARS-CoV-2 (COVID-19) Severe Pneumonia
1 drug in this indication
Interstitial Lung Disease
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in aTyr Pharma, Inc.'s drug pipeline?β
CatalystAlert tracks 4 drug candidates in aTyr Pharma, Inc.'s (LIFE) pipeline across Phase 3, Phase 2. Its lead program is Efzofitimod 3 mg/kg (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is aTyr Pharma, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for aTyr Pharma, Inc. (LIFE) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track LIFE biotech catalysts?β
Add LIFE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow aTyr Pharma, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
